IE44449L - Morphanthridines - Google Patents

Morphanthridines

Info

Publication number
IE44449L
IE44449L IE761723A IE172376A IE44449L IE 44449 L IE44449 L IE 44449L IE 761723 A IE761723 A IE 761723A IE 172376 A IE172376 A IE 172376A IE 44449 L IE44449 L IE 44449L
Authority
IE
Ireland
Prior art keywords
hydrogen
carbon atoms
morphanthridines
ca1070685a
psychotics
Prior art date
Application number
IE761723A
Other versions
IE44449B1 (en
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of IE44449L publication Critical patent/IE44449L/en
Publication of IE44449B1 publication Critical patent/IE44449B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/20—Dibenz [b, e] azepines; Hydrogenated dibenz [b, e] azepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Case 500-5386 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS This invention provides new compounds of formula I, I wherein R1 is hydrogen, alkyl of 1 to 4 carbon atoms, or hydroxyalkyl of 1 to 4 carbon atoms, and R2 is hydrogen or halogen, useful as anti-psychotics and sleep-inducing agents. [CA1070685A]
IE1723/76A 1975-08-06 1976-08-04 11-methylene-6-piperazinyl-morphanthridine derivatives IE44449B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1024775A CH601287A5 (en) 1975-08-06 1975-08-06

Publications (2)

Publication Number Publication Date
IE44449L true IE44449L (en) 1977-02-06
IE44449B1 IE44449B1 (en) 1981-12-02

Family

ID=4361070

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1723/76A IE44449B1 (en) 1975-08-06 1976-08-04 11-methylene-6-piperazinyl-morphanthridine derivatives

Country Status (21)

Country Link
JP (1) JPS5219690A (en)
AU (1) AU1661376A (en)
BE (1) BE844881A (en)
CA (1) CA1070685A (en)
CH (1) CH601287A5 (en)
DE (1) DE2633782A1 (en)
DK (1) DK342976A (en)
ES (1) ES450498A1 (en)
FI (1) FI62664C (en)
FR (1) FR2320103A1 (en)
GB (1) GB1551442A (en)
GR (1) GR70677B (en)
IE (1) IE44449B1 (en)
IL (1) IL50198A0 (en)
NL (1) NL7608567A (en)
NO (1) NO145538C (en)
NZ (1) NZ181684A (en)
PH (1) PH11347A (en)
PT (1) PT65435B (en)
SE (1) SE7608519L (en)
ZA (1) ZA764731B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH624682A5 (en) * 1976-11-10 1981-08-14 Sandoz Ag
DE2918778A1 (en) * 1979-05-10 1980-11-20 Basf Ag 6-SUBSTITUTED 11-ALKYLENE MORPHANTRIDINE
IT1207417B (en) * 1982-03-15 1989-05-17 Menarini Sas AZEPINA-6-ONE WITH ACTIVITIES TRICYCLIC COMPOUNDS DERIVED FROM PHARMACOLOGICAL, AND PROCEDURES OF 5,6-DIHYDRO-11H-DIBENZO (B, E) RELATED MANUFACTURE
JPS6266910U (en) * 1985-10-11 1987-04-25

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3389139A (en) * 1963-06-14 1968-06-18 Wander Ag Dr A 6-homopiperazino and piperazinomorphanthridines
CH436308A (en) * 1964-05-27 1967-05-31 Wander Ag Dr A Process for the preparation of 6-basic substituted morphanthridines
DE1670053A1 (en) * 1966-02-18 1970-08-13 Boehringer Mannheim Gmbh Process for the preparation of new derivatives of morphanthridine

Also Published As

Publication number Publication date
JPS5219690A (en) 1977-02-15
DK342976A (en) 1977-02-07
NO762644L (en) 1977-02-08
ZA764731B (en) 1978-03-29
FI62664C (en) 1983-02-10
NL7608567A (en) 1977-02-08
CH601287A5 (en) 1978-07-14
PT65435A (en) 1976-09-01
BE844881A (en) 1977-02-04
ES450498A1 (en) 1977-12-16
IE44449B1 (en) 1981-12-02
NO145538B (en) 1982-01-04
AU1661376A (en) 1978-02-09
NO145538C (en) 1982-04-14
PT65435B (en) 1978-05-10
NZ181684A (en) 1978-04-28
FI762153A (en) 1977-02-07
PH11347A (en) 1977-11-02
SE7608519L (en) 1977-02-07
DE2633782A1 (en) 1977-02-17
FR2320103A1 (en) 1977-03-04
IL50198A0 (en) 1976-10-31
GR70677B (en) 1982-12-06
FR2320103B1 (en) 1978-12-22
FI62664B (en) 1982-10-29
CA1070685A (en) 1980-01-29
GB1551442A (en) 1979-08-30

Similar Documents

Publication Publication Date Title
IE781619L (en) Phosphonoacyl proline compounds.
ES405983A1 (en) N-fluoroalkylated phenylethylamine
IE872588L (en) Compounds
ES8505518A1 (en) Amino-acids derivatives, process for their preparation and their use.
ES8201947A1 (en) 9-Aminoalkylfluorenes, process therefor and antiarrhythmic formulations thereof.
ES8101550A1 (en) Pyrrolidine-2-methanol derivatives, process for their preparation and medicaments containing them.
IE44316L (en) Indazole derivatives.
ES8400752A1 (en) Derivatives of cyclophosphamide, process for their preparation and their use.
ES481551A1 (en) Bis(aryloxy-alcanecarboxylic compounds, their preparation and their therapeutic use.
IE44449L (en) Morphanthridines
FR2518538B1 (en)
FR2498184B1 (en)
ES454823A1 (en) Derivatives of imidazo 1,2-a pyridine
ES447751A1 (en) Imidazolyl-2-quinazoline derivatives
ES451466A1 (en) 5-thiazole-methane-amines, and their use as antilipolytics
ES465929A1 (en) 2 - phenyl - picyclic - 1,2,4 - triazoles and their use as herbicides
ES8205414A1 (en) Thiazole derivatives, their preparation and use in therapeutics.
ES464150A1 (en) Combatting ectoparasites with phenylaminoalkyl-2-imidazoline compounds
DE3172309D1 (en) Substituted 3,5-diamino-1,2,4-oxadiazoles and 3,5-diamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions containing them
ES451772A1 (en) Dibenzo(b,e)-(1,4)diazepines
IE780982L (en) 4-hydroxythiazoline-2-thiones.
DE3166665D1 (en) Dibenzocycloheptenylidenes and their use in pharmaceutical compositions
IE45258L (en) Tetrahydronaphthalenes
ES463228A1 (en) Substituted-9H-pyrrolo[3,4-b]quinolin-9-ones and treatment of allergic conditions with them
ES456639A1 (en) Cyclopenta{8 B{9 thiophene derivatives